Cell Press Webinar: Harnessing Metabolic Reprogramming for Translational Therapy in Cancer


Monday, May 6, 2019, 12:00pm to 1:00pm


Online event

Synthetic biology technologies have ushered in remarkable advances in cellular engineering, growing our arsenal of tools for cancer treatment. Increasingly, the metabolic pathways of cells have emerged as attractive targets for rewiring cell behavior, enhancing the efficacy of such treatments as T cell-receptor (TCR)- and chimeric antigen receptor (CAR)-based immunotherapies. In this Cell Press Webinar, Shikhar Mehrotra (Medical University of South Carolina), Greg Delgoffe (University of Pittsburgh), and Jeff Rathmell (Vanderbilt University Medical Center), and Nicholas Restifo (National Cancer Institute, NIH) will explore the interplay between cancer and immunometabolism with an eye to recent innovations in the therapeutic landscape.

More info and registration here.